Zydus receives Orphan Drug Designation from US FDA for malaria treatment
The Orphan Drug Designation provides up to seven years of marketing exclusivity in the US
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
malaria treatment
Ganaplacide/lumefantrine combination show positive results in children with malaria
The combination, in the phase-IIb study conducted by Novartis and MMV, has the potential not only to clear malaria infection,…